Citation:Van den Hout WB, Kramer GW, Noordijk EM, Leer JW 2006

From Cancer Guidelines Wiki

Citation


van den Hout WB, Kramer GW, Noordijk EM, Leer JW. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer. J Natl Cancer Inst 2006 Dec 20;98(24):1786-94 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17179480.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?Dr Margot Lehman MBBS FRANZCR GDPcompleted
What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Emma.dickins/Sandbox
  2. What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?